Children and SARS-CoV-2.
Journal
Cell host & microbe
ISSN: 1934-6069
Titre abrégé: Cell Host Microbe
Pays: United States
ID NLM: 101302316
Informations de publication
Date de publication:
14 07 2021
14 07 2021
Historique:
entrez:
15
7
2021
pubmed:
16
7
2021
medline:
30
7
2021
Statut:
ppublish
Résumé
A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss what remains unknown.
Identifiants
pubmed: 34265242
pii: S1931-3128(21)00297-3
doi: 10.1016/j.chom.2021.06.015
pmc: PMC8279573
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1040-1042Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Références
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Immunity. 2020 Jun 16;52(6):910-941
pubmed: 32505227
Cell. 2020 Nov 12;183(4):968-981.e7
pubmed: 32966765
J Clin Invest. 2021 May 17;131(10):
pubmed: 33705359
Cell Rep. 2021 Mar 16;34(11):108852
pubmed: 33730580
PLoS Med. 2016 Mar 24;13(3):e1001977
pubmed: 27011229
JAMA Netw Open. 2021 Apr 1;4(4):e215298
pubmed: 33835179
Mod Pathol. 2020 Nov;33(11):2104-2114
pubmed: 32561849
Cell. 2020 Nov 12;183(4):982-995.e14
pubmed: 32991843
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Sci Immunol. 2021 Mar 2;6(57):
pubmed: 33653907
Immunity. 2021 May 11;54(5):1083-1095.e7
pubmed: 33891889
J Exp Med. 2021 Jun 7;218(6):
pubmed: 33904890
JAMA Pediatr. 2020 Sep 01;174(9):882-889
pubmed: 32320004
BMJ. 2020 May 22;369:m1985
pubmed: 32444460